177 related articles for article (PubMed ID: 10492238)
1. Ep-Cam levels in prostatic adenocarcinoma and prostatic intraepithelial neoplasia.
Poczatek RB; Myers RB; Manne U; Oelschlager DK; Weiss HL; Bostwick DG; Grizzle WE
J Urol; 1999 Oct; 162(4):1462-6. PubMed ID: 10492238
[TBL] [Abstract][Full Text] [Related]
2. Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases.
Bostwick DG; Pacelli A; Blute M; Roche P; Murphy GP
Cancer; 1998 Jun; 82(11):2256-61. PubMed ID: 9610707
[TBL] [Abstract][Full Text] [Related]
3. Changes in biomarker expression in the development of prostatic adenocarcinoma.
Myers RB; Grizzle WE
Biotech Histochem; 1997 Mar; 72(2):86-95. PubMed ID: 9152521
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of retinoblastoma and p53 tumor suppressor genes in prostatic intraepithelial neoplasia: comparison with prostatic adenocarcinoma and benign prostate.
Tamboli P; Amin MB; Xu HJ; Linden MD
Mod Pathol; 1998 Mar; 11(3):247-52. PubMed ID: 9521470
[TBL] [Abstract][Full Text] [Related]
5. Expression of Ep-CAM in intestinal metaplasia, gastric epithelial dysplasia and gastric adenocarcinoma.
Joo M; Kim H; Kim MK; Yu HJ; Kim JP
J Gastroenterol Hepatol; 2005 Jul; 20(7):1039-45. PubMed ID: 15955212
[TBL] [Abstract][Full Text] [Related]
6. Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker.
Darson MF; Pacelli A; Roche P; Rittenhouse HG; Wolfert RL; Young CY; Klee GG; Tindall DJ; Bostwick DG
Urology; 1997 Jun; 49(6):857-62. PubMed ID: 9187691
[TBL] [Abstract][Full Text] [Related]
7. Expression of Ep-CAM in normal, regenerating, metaplastic, and neoplastic liver.
de Boer CJ; van Krieken JH; Janssen-van Rhijn CM; Litvinov SV
J Pathol; 1999 Jun; 188(2):201-6. PubMed ID: 10398165
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody 9C4 recognizes epithelial cellular adhesion molecule, a cell surface antigen expressed in early steps of erythropoiesis.
Lammers R; Giesert C; Grünebach F; Marxer A; Vogel W; Bühring HJ
Exp Hematol; 2002 Jun; 30(6):537-45. PubMed ID: 12063020
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of the nuclear proliferative index (Ki-67) in benign prostate, prostatic intraepithelial neoplasia, and prostatic carcinoma.
Tamboli P; Amin MB; Schultz DS; Linden MD; Kubus J
Mod Pathol; 1996 Oct; 9(10):1015-9. PubMed ID: 8902840
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor-binding protein-2 and -3 expression in benign human prostate epithelium, prostate intraepithelial neoplasia, and adenocarcinoma of the prostate.
Tennant MK; Thrasher JB; Twomey PA; Birnbaum RS; Plymate SR
J Clin Endocrinol Metab; 1996 Jan; 81(1):411-20. PubMed ID: 8550786
[TBL] [Abstract][Full Text] [Related]
11. Expression of MUC 1 and Ep-CAM in Merkel cell carcinomas: implications for immunotherapy.
Kurzen H; Kaul S; Egner U; Deichmann M; Hartschuh W
Arch Dermatol Res; 2003 Aug; 295(4):146-54. PubMed ID: 12844224
[TBL] [Abstract][Full Text] [Related]
12. Specific targeting of Ep-CAM in various carcinomas by novel monoclonal antibodies.
Sithambaram D; Palanivelu S; Subramanian K; Sahoo S; Verma RS
Hybridoma (Larchmt); 2011 Dec; 30(6):511-8. PubMed ID: 22149275
[TBL] [Abstract][Full Text] [Related]
13. [Expression and significance of activated leukocyte cell adhesion molecule in prostatic intraepithelial neoplasia and adenocarcinoma].
Zheng X; Ding W; Xie L; Chen Z
Zhonghua Nan Ke Xue; 2004 Apr; 10(4):265-8. PubMed ID: 15148921
[TBL] [Abstract][Full Text] [Related]
14. The biology of the 17-1A antigen (Ep-CAM).
Balzar M; Winter MJ; de Boer CJ; Litvinov SV
J Mol Med (Berl); 1999 Oct; 77(10):699-712. PubMed ID: 10606205
[TBL] [Abstract][Full Text] [Related]
15. Expression of p160erbB-3 and p185erbB-2 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma.
Myers RB; Srivastava S; Oelschlager DK; Grizzle WE
J Natl Cancer Inst; 1994 Aug; 86(15):1140-5. PubMed ID: 7913137
[TBL] [Abstract][Full Text] [Related]
16. Expression of tumor-associated glycoprotein 72 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma.
Myers RB; Schlom J; Srivastava S; Grizzle WE
Mod Pathol; 1995 Apr; 8(3):260-5. PubMed ID: 7617651
[TBL] [Abstract][Full Text] [Related]
17. Glycoprotein A-80 in the human prostate: immunolocalization in prostatic intraepithelial neoplasia, carcinoma, radiation failure, and after neoadjuvant hormonal therapy.
Coogan CL; Bostwick DG; Bloom KJ; Gould VE
Urology; 2003 Jan; 61(1):248-52. PubMed ID: 12559317
[TBL] [Abstract][Full Text] [Related]
18. Amphiregulin expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 93 cases.
Bostwick DG; Qian J; Maihle NJ
Prostate; 2004 Feb; 58(2):164-8. PubMed ID: 14716741
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Pim-1 during progression of prostatic adenocarcinoma.
Cibull TL; Jones TD; Li L; Eble JN; Ann Baldridge L; Malott SR; Luo Y; Cheng L
J Clin Pathol; 2006 Mar; 59(3):285-8. PubMed ID: 16505280
[TBL] [Abstract][Full Text] [Related]
20. Evidence for a role of the epithelial glycoprotein 40 (Ep-CAM) in epithelial cell-cell adhesion.
Litvinov SV; Bakker HA; Gourevitch MM; Velders MP; Warnaar SO
Cell Adhes Commun; 1994 Oct; 2(5):417-28. PubMed ID: 7842256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]